Free Trial
→ Trump’s Back, but DC’s Coming for Your Money! (From Genesis Gold Group) (Ad) Free YMAB Stock Alerts

Y-mAbs Therapeutics (YMAB) SEC Filings & 10K Form

Y-mAbs Therapeutics logo
$11.14 -0.45 (-3.88%)
(As of 11/15/2024 ET)
Compare

Recent Y-mAbs Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
11/14/2024
3:32 PM		Paradigm Biocapital Advisors LP (Filed by)
Y-mAbs Therapeutics (Subject)
Form SC 13G/A
11/08/2024
6:18 AM		Y-mAbs Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2024
5:55 AM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
1:16 PM		VANGUARD GROUP INC (Filed by)
Y-mAbs Therapeutics (Subject)
Form SC 13G/A
11/04/2024
7:51 AM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
7:05 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:24 PM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
3:19 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
6:06 AM		Y-mAbs Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
5:50 AM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
3:15 PM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
4:29 PM		PFREUNDSCHUH PETER P. (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
6:59 PM		PFREUNDSCHUH PETER P. (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/01/2024
3:20 PM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
8:00 PM		TYAGI ASHU (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:00 PM		GILL DAVID N (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:01 PM		HEALY JAMES (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:01 PM		Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:02 PM		Hamill Laura (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:02 PM		TAGLIAFERRI MARY (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:05 PM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
6:53 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:54 PM		Ber Gerard (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:44 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2024
8:36 PM		Kruse Bo (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:54 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:42 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/29/2024
4:04 PM		Y-mAbs Therapeutics (Filer)
Form DEFA14A
04/29/2024
4:05 PM		Y-mAbs Therapeutics (Filer)
Form ARS
04/29/2024
4:09 PM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2024
4:09 PM		Paradigm Biocapital Advisors LP (Filed by)
Y-mAbs Therapeutics (Subject)
Form SC 13G
03/14/2024
4:01 PM		TAGLIAFERRI MARY (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
8:17 AM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2024
5:17 AM		TAGLIAFERRI MARY (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/07/2024
4:02 PM		Rajah Vignesh (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:49 PM		Smith Susan Laura (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
3:40 PM		Rajah Vignesh (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
6:05 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
5:05 AM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
4:04 PM		Y-mAbs Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/06/2024
2:59 PM		ACORN BIOVENTURES, L.P. (Filed by)
Y-mAbs Therapeutics (Subject)
Form SC 13G/A
Strange: Why is Amazon suddenly yielding 39.70%? (Ad)

Something big is happening with Amazon stock… While most investors collect ZERO dividends from Amazon… A small group just discovered a "backdoor" way to collect yields up to 39.70%!

Click here to see this breakthrough before everyone else →
01/22/2024
4:54 PM		Lund-Hansen Torben (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
4:56 PM		Wilms Joris (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
4:58 PM		Lisby Steen (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
5:00 PM		Smith Susan Laura (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
5:02 PM		Rajah Vignesh (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
4:48 PM		Kruse Bo (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
4:52 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
5:45 AM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2023
3:15 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
6:40 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
3:40 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
7:27 AM		WG Biotech ApS (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
7:26 AM		Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
4:25 PM		Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
4:25 PM		WG Biotech ApS (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
4:14 PM		Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
4:15 PM		WG Biotech ApS (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2023
4:14 PM		WG Biotech ApS (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2023
4:15 PM		Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:YMAB) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners
Bill Gates’s Next Big AI Bet: Stargate
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...
Brownstone Research | Sponsored
The Crypto That’s Making Wall Street Sweat
The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...
Crypto 101 Media | Sponsored
There is a little known company that is changing warfare
With geo - political instability around the world investors are flocking to defense contract stocks. There...
Reticulate | Sponsored
The #1 Crypto for AI
We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...
Weiss Ratings | Sponsored
The pin that pops the AI bubble
My new documentary explores the background to this pattern and how and why I believe it will almost certainly ...
Porter & Company | Sponsored
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
24/7 Automated Profits in Crypto
What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...
Crypto Swap Profits | Sponsored
Trump Wins… But Elon Says Get Ready to Brace
Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...
Genesis Gold Group | Sponsored